SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Candela Medical, Inc. – IPO: ‘RW’ on 9/2/22

On:  Friday, 9/2/22, at 4:08pm ET   ·   Accession #:  1193125-22-237911   ·   File #:  333-259981

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/02/22  Candela Medical, Inc.             RW                     1:9K                                     Donnelley … Solutions/FA

Initial Public Offering (IPO):  Registration Withdrawal Request

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: RW          Registration Withdrawal Request                     HTML      9K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  RW  

September 2, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:    Margaret Schwartz
   Celeste Murphy

 

Re:

Candela Medical, Inc.

Application for Withdrawal of Registration Statement on Form S-1

(File No. 333- 259981)

Ladies and Gentlemen:

Reference is made to the Registration Statement on Form S-1 initially filed with the Securities and Exchange Commission (the “Commission”) by Candela Medical, Inc. (the “Registrant”) on October 1, 2021 (File No. 333- 259981) (the “Registration Statement”). Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the Registrant hereby applies for the withdrawal of the Registration Statement, together with all exhibits thereto, effective as of the date of this application or as soon as practicable thereafter.

The Registrant has determined not to proceed with the proposed initial public offering of the securities contemplated by the Registration Statement at this time. Because the proposed offering will not occur, the Registrant believes that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a) of the Securities Act.

The Registration Statement has not been declared effective by the Commission and the Registrant confirms that it has not sold any securities pursuant to the Registration Statement.

The Registrant acknowledges that no refund will be made for fees paid to the Commission in connection with filing of the Registration Statement. The Registrant, however, requests that, in accordance with Rule 457(p) promulgated under the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.

It is the Registrant’s understanding that this application for withdrawal of the Registration Statement will be deemed granted as of the date that it is filed with the Commission unless, within fifteen calendar days after such date, the Registrant receives notice from the Commission that this application will not be granted.


Should you have any questions regarding the foregoing application for withdrawal of the Registration Statement or if withdrawal will not be granted, please contact Kenneth B. Wallach of Simpson Thacher & Bartlett LLP at (212) 455-3352.

 

Sincerely,
Candela Medical, Inc.

/s/ Ernest Orticerio

Name:   Ernest Orticerio
Title:   Chief Financial Officer

 

cc:

Simpson Thacher & Bartlett LLP

Kenneth B. Wallach

Sunny Cheong

 

2


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘RW’ Filing    Date    Other Filings
Filed on:9/2/22
10/1/21DRS,  DRS/A,  S-1
 List all Filings 
Top
Filing Submission 0001193125-22-237911   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 16, 5:19:53.0pm ET